tiprankstipranks
Leap Therapeutics (LPTX)
:LPTX
US Market

Leap Therapeutics (LPTX) Income Statement

Compare
887 Followers

Leap Therapeutics Income Statement

Last quarter (Q3 2024), Leap Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Leap Therapeutics's net income was $-18.18M. See Leap Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 1.50M$ 1.50M$ 0.00
Gross Profit
$ -427.00K$ -415.00K$ 1.50M$ 1.50M$ -776.00K
Operating Expenses
$ 86.61M$ 54.71M$ 41.70M$ 29.81M$ 33.32M
Depreciation and Amortization
$ 427.00K$ 415.00K$ 556.00K$ 668.00K$ 776.00K
EBITDA
$ -80.99M$ -53.98M$ -40.01M$ -26.81M$ -32.10M
Operating Income
$ -87.04M$ -56.76M$ -41.43M$ -28.54M$ -33.45M
Other Income/Expenses
$ 5.63M$ 2.31M$ 815.00K$ 1.02M$ 548.00K
Pretax Income
$ -81.41M$ -54.45M$ -40.61M$ -27.52M$ -32.90M
Net Income
$ -81.41M$ -54.60M$ -40.59M$ -27.51M$ -32.90M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.98$ -4.82$ -4.73$ -4.64$ -14.57
Diluted EPS
$ -3.98$ -4.82$ -4.73$ -4.64$ -14.57
Weighted Average Shares Outstanding
20.45M 11.32M 8.58M 5.93M 2.26M
Weighted Average Shares Outstanding (Diluted)
20.45M 11.32M 8.58M 5.93M 2.26M
Currency in USD

Leap Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis